SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000; 59: 26870.
  • 2
    Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 18238.
  • 3
    Brown MA, Edwards S, Hoyle E, Campbell S, Laval S, Daly AK, et al. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 2000; 9: 15636.
  • 4
    Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1996; 55: 668.
  • 5
    Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998; 41: 58895.
  • 6
    Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001; 68: 91826.
  • 7
    Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics 1992; 13: 6547.
  • 8
    Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000; 191: 30312.
  • 9
    McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford) 2001; 40: 135964.
  • 10
    Van der Paardt, van der Horst-Bruinsma IE, Crusius JBA, Baudoin P, Kostense PK, Dijkmans BAC, et al. Interleukin-1β (IL-1B) and interleukin-1 receptor antagonist (IL-1ra) gene polymorphisms in the susceptibility to ankylosing spondylitis (AS) [abstract]. Ann Rheum Dis 2000; 59 Suppl: 117.
  • 11
    Lin RC, Morris BJ. Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 2002; 107: 3116.
  • 12
    Barahamani N, de Andrade M, Slusser J, Zhang Q, Duvic M. Interleukin-1 receptor antagonist allele 2 and familial alopecia areata. J Invest Dermatol 2002; 118: 3357.
  • 13
    Arnalich F, Lopez-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM, Capiscol C, et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002; 127: 3316.
  • 14
    Segman RH, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, et al. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry 2002; 7: 724.
  • 15
    Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 13805.
  • 16
    Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 36974.
  • 17
    Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, et al. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 2001; 48: 4617.
  • 18
    Blakemore AI, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 1115.
  • 19
    Clay FE, Cork MJ, Tarlow JK, Blakemore AI, Harrington CI, Lewis F, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 40710.
  • 20
    Schrijver HM, Crusius JB, Uitdehaag BM, Garcia Gonzalez MA, Kostense PJ, Polman CH, et al. Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 1999; 52: 5959.
  • 21
    Tarlow JK, Cork MJ, Clay FE, Schmitt-Egenolf M, Crane AM, Stierle C, et al. Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 1997; 136: 1478.
  • 22
    Pociot F, Ronningen KS, Bergholdt R, Lorenzen T, Johannesen J, Ye K, et al for the Danish Study Group of Diabetes in Childhood. Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes—evidence for polygenicity in man. Autoimmunity 1994; 19: 16978.
  • 23
    Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 1998; 87: 30913.
  • 24
    Cullup H, Dickinson AM, Jackson GH, Taylor PR, Cavet J, Middleton PG. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113: 80713.
  • 25
    Jarosova K, Nemcova D, Ruzickova S, Cimburek Z, Stork J, Dostal C, et al. Interleukin-1 receptor antagonist gene allele 2 is increased in patients with juvenile idiopathic arthritis [abstract]. Ann Rheum Dis 2000; 59 Suppl: 253.
  • 26
    Edwards S, Timms A, Bradbury L, Wordsworth BP, Brown MA. Interleukin-1 and susceptibility to ankylosing spondylitis [abstract]. Rheumatology (Oxford) 2001; 40 Suppl 1: 17.
  • 27
    Weissbach L, Tran K, Colquhoun SA, Champliaud MF. Detection of an interleukin-1 intracellular receptor antagonist mRNA variant. Biochem Biophys Res Commun 1998; 244: 915.
  • 28
    Reveille JD, Akey J, Bruckel J, Weisman MH, Inman RD, Stone M, et al. The interleukin receptor-1 antagonist (IL-1Ra) gene is involved in predisposition to ankylosing spondylitis (AS) [abstract]. Arthritis Rheum 2002; 46 Suppl 9: S620.
  • 29
    Buetow KH, Edmondson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001; 98: 5814.
  • 30
    Akey J, Jin L, Xiong M. Haplotype vs single marker linkage disequilibrium test: what do we gain? Eur J Hum Genet 2001; 9: 291300.
  • 31
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 3618.
  • 32
    Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001; 11: 14351.
  • 33
    Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000; 67: 94759.
  • 34
    Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 9217.
  • 35
    Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 97889.
  • 36
    Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000; 50: 1339.
  • 37
    Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 837.
  • 38
    Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72: 18590.
  • 39
    Geiser AG, Busam KJ, Kim SJ, Lafyatis R, O'Reilly MA, Webbink R, et al. Regulation of the transforming growth factor-β1 and -β3 promoters by transcription factor Sp1. Gene 1993; 129: 2238.
  • 40
    Danis VA, Millington M, Hyland V, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 30310.
  • 41
    Hurme M, Santilla S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 1998; 28: 2598602.
  • 42
    Andus T, Daig R, Vogl D, Aschenbrenner E, Lock G, Hollerbach S, et al. Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 1997; 41: 6517.
  • 43
    Clay FE, Tarlow JK, Cork MJ, Cox A, Nicklin MJ, Duff GW. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment [abstract]. Hum Genet 1996; 97: 7236.
  • 44
    Carter MJ, Duff GW, Lobo AJ, di Giovine FS. Allele-specific mRNA assessment in colonic mucosa in ulcerative colitis: association of the interleukin-receptor antagonist gene allele 2 with reduced steady state mRNA levels. Gastroenterology 1999; 116: G2952.
  • 45
    Guasch JF, Bertina RM, Reitsma PH. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 1996; 8: 598602.
  • 46
    Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000; 355: 30811.
  • 47
    Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001; 2: 919.
  • 48
    Vieland VJ. The replication requirement. Nat Genet 2001; 29: 2445.
  • 49
    Mansfield JC, Holden H, Tarlow JK, di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 63742.
  • 50
    Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002; 71: 30411.
  • 51
    Brophy S, Hamersma J, Bradbury I, Timms A, Edwards S, Laval S, et al. Towards defining the genetic determinants of disease severity in ankylosing spondylitis [abstract]. Arthritis Rheum 2001; 44 Suppl 9: S160.